Reagents and test kits for covid-19

Ended Awarded

Contract number
HT001420F0245
Awardee
Awarding agency
Obligated
$500,000

Award facts

Contract value 100% obligated
$500,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded Roche Diagnostics Corporation a $500,000 firm fixed price blanket purchase agreement call contract to provide reagents and test kits for COVID-19 testing. The contract was awarded under the National Interest Action Code for coronavirus response and will be performed in Bethesda, Maryland through August 2021. As the prime contractor, Roche will support the Defense Health Agency's efforts to expand COVID-19 testing capacity. No subcontractors or set aside designations were identified in the award information.

Quick answers

Who was awarded contract HT001420F0245?

HT001420F0245 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on August 14, 2020.

How much is contract HT001420F0245 worth?

The government has obligated $500,000 on HT001420F0245.

Is contract HT001420F0245 an order under another contract?

Yes. HT001420F0245 is a BPA call under HT001419A0031, a blanket purchase agreement.

Was contract HT001420F0245 competed?

The extent of competition for HT001420F0245 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award